Select a medication above to begin.
Pyquvi
deflazacort
Adult Dosing .
Dosage forms: SUSP: 22.75 mg per mL
New FDA Approval: June 2025
- [content coming soon]
Duchenne muscular dystrophy
- [content coming soon]
- Info: exact mechanism of action unknown; exerts anti-inflammatory, immunosuppressive effects via glucocorticoid receptors
Peds Dosing .
- Dosage forms: SUSP: 22.75 mg per mL
New FDA Approval: June 2025
- [content coming soon]
Duchenne muscular dystrophy
- [content coming soon]
- Info: exact mechanism of action unknown; exerts anti-inflammatory, immunosuppressive effects via glucocorticoid receptors